-Advertisement-

Teva Buying Ivax for $7.4B

July 24, 2005

Teva Pharmaceutical Industries Ltd., which bought Irvine’s Sicor Inc. in early 2004, has agreed to buy rival Ivax Corp. for $7.4 billion in a deal that vaults the Israeli company back as the biggest maker of generic drugs.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

Mind the GAAP: Private Companies Want Accounting Fixes

Rockwell Collins Back After 2002 Relocation

staff-author

-Advertisement-

Featured Articles

-Advertisement-

Teva Buying Ivax for $7.4B

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Redesigned Apple Watches Don’t Infringe Masimo Patents, ITC Juge Finds

Super73 Launches E-Bikes with New Battery Technology

Midday Stock Roundup: Rivian Stock Rises 3.5% on $1.25B Investment from Uber

Related Articles

Redesigned Apple Watches Don’t Infringe Masimo Patents, ITC Juge Finds

Super73 Launches E-Bikes with New Battery Technology

Midday Stock Roundup: Rivian Stock Rises 3.5% on $1.25B Investment from Uber

Uber Invests $1.25B in Rivian Automotive for R2 Robotaxis

13 New Tenants Confirmed for The Canopy at Great Park

Advertise With Us

About Us

Subscriber Links

Other Journals